These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
14. Morphological features and apoptosis in the left internal thoracic artery grafts before implantation. Kouzi-Koliakos K; Kanellaki-Kyparissi M; Marinov G; Tsalie E; Pavlidou E; Knyazhev V; Kovatchev D Int Angiol; 2007 Mar; 26(1):38-48. PubMed ID: 17353887 [TBL] [Abstract][Full Text] [Related]
16. Reduced neointima in vein grafts following a blockage of cell recruitment from the vein and the surrounding tissue. Fogelstrand P; Osterberg K; Mattsson E Cardiovasc Res; 2005 Aug; 67(2):326-32. PubMed ID: 15885671 [TBL] [Abstract][Full Text] [Related]
17. Immunocytochemical determination of cell type and proliferation rate in human vein graft stenoses. Westerband A; Mills JL; Marek JM; Heimark RL; Hunter GC; Williams SK J Vasc Surg; 1997 Jan; 25(1):64-73. PubMed ID: 9013909 [TBL] [Abstract][Full Text] [Related]
18. [Histological study of saphenous vein graft disease after coronary artery bypass grafting]. Kobayashi T; Fuse K; Naruse Y; Watanabe Y; Konishi H Nihon Kyobu Geka Gakkai Zasshi; 1993 Apr; 41(4):592-7. PubMed ID: 8515157 [TBL] [Abstract][Full Text] [Related]
19. Wild-type p53 gene transfer inhibits neointima formation in human saphenous vein by modulation of smooth muscle cell migration and induction of apoptosis. George SJ; Angelini GD; Capogrossi MC; Baker AH Gene Ther; 2001 May; 8(9):668-76. PubMed ID: 11406761 [TBL] [Abstract][Full Text] [Related]
20. Role of osteopontin in the development of neointimal hyperplasia in vein grafts. Kang N; Ng CS; Hu J; Qiu ZB; Underwood MJ; Jeremy JY; Wan S Eur J Cardiothorac Surg; 2012 Jun; 41(6):1384-9. PubMed ID: 22219474 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]